Cite

HARVARD Citation

    Ramos, G. et al. (2021). The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflammatory bowel diseases. 27 (8), pp. 1270-1276. [Online]. 
  
Back to record